MODOPAR Side Effects

5835762-X | Hypotension, Loss Of Consciousness, Thrombocytopenia
on Jul 30, 2008 Male patient from FRANCE , 86 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?), agitation, prostatic disorder and was treated with Modopar (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, loss of consciousness, thrombocytopenia. Modopar dosage: Unk. During the same period patient was treated with RIVOTRIL (View Rivotril Review and Rivotril Label ), XATRAL (View Xatral Review and Xatral Label ). Patient was hospitalized.

5264759-6 | Asthenia, Blood Glucose Increased, Blood Urea Increased, C-reactive Protein Increased, Confusional State, Haematemesis, Hallucination, Visual, Hypertonia, Hypoglycaemic Coma
Patient was taking Modopar (View Usage). Patient had the following side effects: asthenia, blood glucose increased, blood urea increased, c-reactive protein increased, confusional state, haematemesis, hallucination, visual, hypertonia, hypoglycaemic coma on Mar 05, 2007 from FRANCE Additional patient health information: Female patient , 96 years of age, weighting 121.3 lb, . Modopar dosage: 1 Df, Tid. During the same period patient was treated with TRIVASTAL (20 Mg, Tid) (View Trivastal Review and Trivastal Label ), DAFLON (1000 Mg, Qd) (View Daflon Review and Daflon Label ), METEOXANE (2 Df, Tid) (View Meteoxane Review and Meteoxane Label ), MOVICOL (Unk, Prn) (View Movicol Review and Movicol Label ), SERESTA (View Seresta Review and Seresta Label ), KARDEGIC (75 Mg, Qd) (View Kardegic Review and Kardegic Label ), ESOMEPRAZOLE MAGNESIUM (1 Df, Cont (synringe Pump)) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.

5264647-5 | Asthenia, Blood Glucose Increased, Blood Urea Increased, C-reactive Protein Increased, Confusional State, Haematemesis, Hallucination, Visual, Hypertonia, Hypoglycaemic Coma
Adverse event was reported on Mar 05, 2007 by a Female patient taking Modopar (View Usage) (Dosage: 1 Df, Tid) . Location: FRANCE , 96 years of age, weighting 121.3 lb, After Modopar was administered, patient had the following side effects: asthenia, blood glucose increased, blood urea increased, c-reactive protein increased, confusional state, haematemesis, hallucination, visual, hypertonia, hypoglycaemic coma. During the same period patient was treated with TRIVASTAL (20 Mg, Tid) (View Trivastal Review and Trivastal Label ), DAFLON (1000 Mg, Qd) (View Daflon Review and Daflon Label ), METEOXANE (2 Df, Tid) (View Meteoxane Review and Meteoxane Label ), MOVICOL (Unk, Prn) (View Movicol Review and Movicol Label ), SERESTA (View Seresta Review and Seresta Label ), KARDEGIC (75 Mg, Qd) (View Kardegic Review and Kardegic Label ), ESOMEPRAZOLE MAGNESIUM (1 Df, Cont (synringe Pump)) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.

5261801-3 | Asthenia, Blood Glucose Increased, Blood Urea Increased, C-reactive Protein Increased, Confusional State, Haematemesis, Hallucination, Visual, Hypertonia, Hypoglycaemic Coma
on Mar 05, 2007 Female patient from FRANCE , 96 years of age, weighting 121.3 lb, was treated with Modopar (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood glucose increased, blood urea increased, c-reactive protein increased, confusional state, haematemesis, hallucination, visual, hypertonia, hypoglycaemic coma. Modopar dosage: 1 Df, Tid. During the same period patient was treated with TRIVASTAL (20 Mg, Tid) (View Trivastal Review and Trivastal Label ), DAFLON (1000 Mg, Qd) (View Daflon Review and Daflon Label ), METEOXANE (2 Df, Tid) (View Meteoxane Review and Meteoxane Label ), MOVICOL (Unk, Prn) (View Movicol Review and Movicol Label ), SERESTA (View Seresta Review and Seresta Label ), KARDEGIC (75 Mg, Qd) (View Kardegic Review and Kardegic Label ), ESOMEPRAZOLE MAGNESIUM (1 Df, Cont (synringe Pump)) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.


5243773-0 | Asthenia, Blood Glucose Increased, Blood Urea Increased, C-reactive Protein Increased, Confusional State, Haematemesis, Hallucination, Visual, Hypertonia, Hypoglycaemic Coma
on Feb 19, 2007 Female patient from FRANCE , 96 years of age, weighting 121.3 lb, was treated with Modopar (View Usage). Patient had the following side effects: asthenia, blood glucose increased, blood urea increased, c-reactive protein increased, confusional state, haematemesis, hallucination, visual, hypertonia, hypoglycaemic coma. Modopar dosage: 1 Df, Tid. During the same period patient was treated with TRIVASTAL (20 Mg, Tid) (View Trivastal Review and Trivastal Label ), DAFLON (1000 Mg, Qd) (View Daflon Review and Daflon Label ), METEOXANE (2 Df, Tid) (View Meteoxane Review and Meteoxane Label ), MOVICOL (Unk, Prn) (View Movicol Review and Movicol Label ), SERESTA (View Seresta Review and Seresta Label ), KARDEGIC (75 Mg, Qd) (View Kardegic Review and Kardegic Label ), ESOMEPRAZOLE MAGNESIUM (1 Df, Cont (synringe Pump)) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.

5078467-8 | Brain Natriuretic Peptide Increased, Cardiac Murmur, Dyspnoea, Mitral Valve Incompetence, Productive Cough, Pulmonary Hypertension, Pyrexia
Patient was taking Modopar (View Usage). After Modopar was administered, patient had the following side effects: brain natriuretic peptide increased, cardiac murmur, dyspnoea, mitral valve incompetence, productive cough, pulmonary hypertension (What is pulmonary hypertension?), pyrexia on Aug 07, 2006 from FRANCE Additional patient health information: Female patient , 76 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Modopar dosage: 1 Df, Qd. During the same period patient was treated with REQUIP (3 Df, Qd) (View Requip Review and Requip Label ), COMTAN (4 Df, Qd) (View Comtan Review and Comtan Label ). Patient was hospitalized.

5005129-5 | Akinesia, Extrapyramidal Disorder, Hallucination, Visual, Impaired Self-care
Adverse event was reported on May 09, 2006 by a Female patient taking Modopar (View Usage) (Dosage: 1 G Daily) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: FRANCE , 68 years of age, Patient experienced the following unwanted or unexpected effects: akinesia, extrapyramidal disorder, hallucination, visual, impaired self-care. During the same period patient was treated with TRIVASTAL (View Trivastal Review and Trivastal Label ), DEPRENYL (5 Mg Daily) (View Deprenyl Review and Deprenyl Label ), COMTAN (200 Mg, Qid) (View Comtan Review and Comtan Label ). Patient was hospitalized.

4899063-9 | Anxiety, Dyspnoea, Leukaemia, Sinus Arrhythmia
on Jul 19, 2005 Male patient from UNITED STATES , 71 years of age, was treated with Modopar (View Usage). Patient had the following side effects: anxiety (What is anxiety?), dyspnoea, leukaemia, sinus arrhythmia. Modopar dosage: 25/100 Mg X 3/day. During the same period patient was treated with PARLODEL (60 Mg/day) (View Parlodel Review and Parlodel Label ), URBANYL (10 Mg/day) (View Urbanyl Review and Urbanyl Label ), EFFERALGAN (4 G/day) (View Efferalgan Review and Efferalgan Label ), COMTAN (600 Mg/day) (View Comtan Review and Comtan Label ). Patient was hospitalized.

4899057-3 | Abnormal Behaviour, Hypertonia, Mutism
on Jan 26, 2006 Female patient from FRANCE , 84 years of age, was diagnosed with dementia (What is dementia?) and was treated with Modopar (View Usage). After Modopar was administered, patient had the following side effects: abnormal behaviour, hypertonia, mutism. Modopar dosage: 12.5/50 Mg X 1/day. During the same period patient was treated with SINEMET (10/100 Mg X 1/day) (View Sinemet Review and Sinemet Label ), KALEORID (2 G/week) (View Kaleorid Review and Kaleorid Label ), LASILIX (20 Mg/day) (View Lasilix Review and Lasilix Label ), EXELON (1.5 Mg, Bid) (View Exelon Review and Exelon Label ). Patient was hospitalized.

4724870-2 | Anxiety, Dyspnoea, Leukaemia, Sinus Arrhythmia
Patient was taking Modopar (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), dyspnoea, leukaemia, sinus arrhythmia on Jul 19, 2005 from FRANCE Additional patient health information: Male patient , 71 years of age, . Modopar dosage: 25/100 Mg X 3/day. During the same period patient was treated with PARLODEL (60 Mg/day) (View Parlodel Review and Parlodel Label ), URBANYL (10 Mg/day) (View Urbanyl Review and Urbanyl Label ), ACETAMINOPHEN (4 G/day) (View Acetaminophen Review and Acetaminophen Label ), COMTAN (600 Mg/day) (View Comtan Review and Comtan Label ). Patient was hospitalized.